Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic hydrogenation route for Lenalidomide. High purity, reduced solvent use, scalable manufacturing for API intermediates.
Patent CN113801062B reveals a novel Grignard-based route for Entrectinib intermediates, offering significant cost reduction and safer manufacturing compared to traditional Suzuki coupling methods.
Patent CN108409648B details an energy-efficient synthesis of sorafenib intermediates with high purity, offering significant cost reduction in API manufacturing and scalable production capabilities.
Advanced preparation method for HER2 inhibitor Tucatinib using Pd(acac)2 catalysis. Offers high purity, simplified purification, and cost-effective manufacturing for pharma supply chains.
Patent CN103408573A reveals a novel NHC-catalyzed borylation method for high-purity boronic acid derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN110862396B reveals a高效 one-step Pd-catalyzed route to pyrrolo[3,4-c]carbazole-1,3-diones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107235910B reveals a high-purity synthesis route for Nilotinib intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN103288757A reveals a novel solid-acid catalyzed nitration route for key TKI intermediates, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturers.
Patent CN108409743A details mild oxidative cyclization using oxygen. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable intermediates.
Patent CN106831474B reveals a one-step rhodium-catalyzed synthesis for anticancer intermediates, offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111675662B details a novel FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Discover the novel 6-step preparation method for CDK4/6 inhibitor SHR6390. Enhanced yield, mild conditions, and scalable process for high-purity pharmaceutical intermediates.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Novel route for (R)-2-(2,5-difluorophenyl)pyrrolidine avoids noble metals, offering cost-effective API manufacturing solutions.
Patent CN115785122A reveals a novel Lewis acid-catalyzed route to indole-piperidine scaffolds with high diastereoselectivity and potent MCF-7 cytotoxicity, offering a scalable solution for API manufacturing.
Patent CN102295638A details a novel one-pot method for Lapatinib synthesis, eliminating toxic tin reagents and improving purity for reliable API intermediate supply chains.
Patent CN118878543A reveals high-purity axial chiral synthesis with significant PC-3 cytotoxic activity and scalable catalytic asymmetric methods for supply chain optimization.
Patent CN110194760B reveals a one-pot Pd-catalyzed route for isoindolinone intermediates, offering high yields and simplified supply chains for API manufacturing.
Patent CN113816955B reveals a high-purity route for RET kinase inhibitor intermediate. Discover cost-effective manufacturing and supply chain advantages.